Who is sponsoring NCT04125004?

NCT04125004 is sponsored by Stanford University.

What drugs are being tested in NCT04125004?

Interventions in NCT04125004: Samsung Virtual Reality Headset.

What condition does NCT04125004 study?

NCT04125004 studies Virtual Reality, General Anesthesia.

Is NCT04125004 still recruiting?

NCT04125004 is currently withdrawn. Last updated 22 March 2021.

Last reviewed 2021-03-22 · How we verify

NCT04125004

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Use of Virtual Reality for Pediatric Minor Surgical Procedures

Withdrawn NA Last updated 22 March 2021

What this trial tests

NA trial testing Samsung Virtual Reality Headset in Virtual Reality. Withdrawn.

Timeline

8 January 2020

Primary endpoint
1 March 2021

1 March 2021

Quick facts

Lead sponsor	Stanford University
Phase	NA
Status	Withdrawn
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	other
Start date	8 January 2020
Primary completion	1 March 2021
Estimated completion	1 March 2021
Sites	1 location across United States

Drugs / interventions tested

Samsung Virtual Reality Headset

Conditions studied

Virtual Reality — all drugs for Virtual Reality →
General Anesthesia — all drugs for General Anesthesia →

Sponsor

Stanford University

Who can join

Adults 7 to 18, any sex, with Virtual Reality or General Anesthesia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This project is looking to use virtual reality for minor general surgery procedures in addition to local anesthesia instead of general anesthesia.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Virtual Reality

Currently open trials in the same condition.

NCT07387107 — Decreasing Stress Via Virtual Reality and Binaural Beats in Non-Clinical Adults · NA · recruiting
NCT07343843 — Virtual Reality Versus Intravenous Dexmedetomidine on Maternal Anxiety, Stress, Hemodynamics, and Neonatal Outcomes Duri · NA · recruiting
NCT07410858 — Virtual Reality-Enhanced Parent Education in Neonatal Intensive Care · NA · recruiting
NCT07021638 — EMMVIES : Walking Training at Home in VIrtual Reality for Children With Chronic Illnesses Impacting Physical Health · NA · recruiting
NCT07236229 — The Effects of Immersive Virtual Reality in Patients With Grade 1-2 Adhesive Capsulitis · NA · recruiting

Other Stanford University trials

Trials by the same sponsor.

NCT05945147 — Ketamine and Midazolam Infusions for CRPS: Feasibility Study · Phase 2 · withdrawn
NCT04225949 — Patients Understanding of PROM Graphs · NA · withdrawn
NCT06273098 — School-Based Bladder Health Intervention · NA · withdrawn
NCT04652635 — Management of Nailbed Injuries · NA · withdrawn
NCT05443503 — Stanford Spine Keeper - Managing Your Low Back Pain · NA · suspended

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04125004 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Stanford University
Last refreshed: 22 March 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04125004.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing